PMC:7160614 / 20348-20468 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"278","span":{"begin":114,"end":117},"obj":"Gene"},{"id":"279","span":{"begin":94,"end":112},"obj":"Gene"},{"id":"294","span":{"begin":78,"end":86},"obj":"Disease"}],"attributes":[{"id":"A278","pred":"tao:has_database_id","subj":"278","obj":"Gene:1401"},{"id":"A279","pred":"tao:has_database_id","subj":"279","obj":"Gene:1401"},{"id":"A294","pred":"tao:has_database_id","subj":"294","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"nts (45.71%), it is not statistically different compared with that in the non-COVID-19 group. C-creative protein (CRP) l"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T47","span":{"begin":105,"end":112},"obj":"Body_part"}],"attributes":[{"id":"A47","pred":"fma_id","subj":"T47","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"nts (45.71%), it is not statistically different compared with that in the non-COVID-19 group. C-creative protein (CRP) l"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T90","span":{"begin":78,"end":86},"obj":"Disease"}],"attributes":[{"id":"A90","pred":"mondo_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"nts (45.71%), it is not statistically different compared with that in the non-COVID-19 group. C-creative protein (CRP) l"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T14","span":{"begin":87,"end":92},"obj":"Chemical"},{"id":"T15","span":{"begin":105,"end":112},"obj":"Chemical"}],"attributes":[{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"nts (45.71%), it is not statistically different compared with that in the non-COVID-19 group. C-creative protein (CRP) l"}